Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Mucinex Survey Reveals Millions Of Americans Hide Being Sick

Enter Mucinex Cold & Flu All in One, Multi-Symptom Relief in One Convenient Formula


News provided by

Mucinex

Oct 09, 2018, 09:00 ET

Share this article

Share toX

Share this article

Share toX

PARSIPPANY, N.J., Oct. 9, 2018 /PRNewswire/ -- A new survey commissioned by Mucinex, the number one over-the-counter brand* in America, reveals that more than 158 million Americans (63 percent of the adult population)1 would try to hide being sick2 so they wouldn't have FOMO (fear of missing out) on doing things they wanted to do. However, more than 206 million Americans (82 percent of those surveyed)3 would agree that when they see people out and about when they are sick, they wish those battling cold and flu symptoms stayed home instead. While this time of year is full of fun autumn activities and outings with family and friends, it's also the beginning of cold and flu season, and the last thing people want to do is stay at home and battle a swarm of sick symptoms.

Continue Reading
Mucinex Survey Results Infographic
Mucinex Survey Results Infographic
Mucinex Cold & Flu All in One
Mucinex Cold & Flu All in One
Get Tough with Mucinex Cold & Flu All in One
Get Tough with Mucinex Cold & Flu All in One

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8419351-mucinex-survey-americans-hide-being-sick/

This fall, millions of Americans who choose to have a "secret sick identity" can instead look to Mucinex for relief. The brand's Mucinex Cold & Flu All in One is a multi-symptom formula that targets and alleviates nine symptoms*. Though 88+ million Americans (35% of those surveyed)4 feel they would be considered superheroes for powering through work despite being sick, Mucinex Cold & Flu All in One can help you fight back and keep symptoms at bay.   

"Mucinex Cold & Flu All in One provides a single, convenient solution for nine cold and flu symptoms, so people can get back to being their superhero selves during these busy fall and winter months," said Brian Dolan, Equity Lead for Mucinex. "When you're sick and feeling miserable, it's really best to stay home and recover, but we all know that life goes on and many people refuse to take sick lying down. Mucinex Cold & Flu All in One can be a secret weapon for those moments."

Gearing up for her debut as a TV hero, actor Minka Kelly knows this scenario all too well. Kelly has partnered with Mucinex to join the battle against sick, showing others how Mucinex Cold & Flu All in One fights symptoms so they don't have to hide under the guise of their "secret sick identities."

"My work and travel schedule means I'm more likely to get sick at a time when I can't let a cold or flu get in my way," said Minka Kelly. "When you get sick, it's never just one thing – there are always multiple symptoms trying to get in your way. Mucinex Cold & Flu All in One relieves nine signs of the cold & flu to help you get back to being your superhero self."

Mucinex's survey also found that people would go to extreme lengths to feel better when getting sick. When asked what people would rather do in exchange for the "super power" of warding off their cold and flu symptoms for the next five years:

  • Nearly half of those surveyed (47 percent) would give up social media for a month.
  • More than a third (37 percent) would give up ordering takeout for a year.
  • Nearly 25 percent would serve jury duty every day for a month.

"People will go to great lengths to feel better when they have cold or flu – even willing to give up social media," continues Dolan. "Our survey results reinforce people's desire to do everything in their power to fend off cold or flu symptoms. Mucinex is the #1 Doctor-Recommended brand in America**, so people can trust our products to help relieve symptoms that keep them from feeling their best."

Mucinex Cold & Flu All-in-One is now available at all major retailers, including CVS, Walgreens, Rite Aid, Walmart and Target. For more information, visit Mucinex.com.

Survey Methodology
This survey was conducted online within the United States by The Harris Poll on behalf of Mucinex from September 6-10, 2018 among 2,026 U.S. adults ages 18 and older. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact Stephanie Duffy ([email protected]) at DeVries Global.

About Mucinex
Mucinex began in 2003 as a 12-hour, OTC chest congestion medication helping to break up mucus and relieve chest congestion. It has rapidly expanded to become the largest U.S. OTC product of any kind in annual dollar sales*** – and the #1 Doctor-Recommended brand in America – offering medicine lines for chest congestion, cough, sinus and multi-symptom relief for adults and children. Mucinex's brand's purpose is rooted in one idea: to relentlessly fight to end the misery of being sick. For more information visit mucinex.com

About RB 
RB is a global leading consumer health and hygiene company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries. From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's unique culture is at the heart of its success. Its drive to achieve, passion to outperform and commitment to quality and scientific excellence are manifested in the work of over 40,000 employees worldwide.

*All of these symptoms: sore throat, fever, chest congestion, cough, nasal congestion, sinus congestion, sinus pressure, headache, body pain
**Based on HCP ProVoice Survey (Cough & Cold symptoms) – Claim substantiation letter, Feb. 7, 2018
***Based on Nielsen dollars sold data, CCFST+ND, FY 2017

1 According to the US Census Bureau, there were an estimated 252,063,800 of Americans 18 and older (July, 2017). 252 x .63 Americans who agree they would try to hide their sick symptoms to do something they wanted to do = 158,800,194 or more than 158 million.
2 For the purposes of this survey, "sick" is defined as cold & flu related symptoms
3 252 x .82 = 206.6 = 206+ million Americans who would agree that those battling cold & flu symptoms should stay home.
4 252 x .35 = 88.2 = 88+ million Americans think they would be considered a "superhero." for powering through work despite having a col

SOURCE Mucinex

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

MUCINEX CHILDREN'S LAUNCHES FIRST CHEWABLE COLD & FLU MEDICINE

MUCINEX CHILDREN'S LAUNCHES FIRST CHEWABLE COLD & FLU MEDICINE

No more negotiating or fighting with your kids to get them to take their medicine. Mucinex Children's, the #1 pediatrician and pharmacist recommended ...

Cold and Flu Symptoms Don't Stand a Chance Against Mucinex® as the Brand Launches its "No Regrets" Campaign with Tinder®, Encouraging Consumers to Make Good Decisions at Night for a Better Morning

Cold and Flu Symptoms Don't Stand a Chance Against Mucinex® as the Brand Launches its "No Regrets" Campaign with Tinder®, Encouraging Consumers to Make Good Decisions at Night for a Better Morning

If there's one regret we can all live without, it's not taking nighttime cold and flu medicine when you're sick, especially when you have a busy day...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Surveys, Polls and Research

Surveys, Polls and Research

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.